MedPath
NMPA Approval

Hydroxycarbamide Tablets

国药准字H11020569

September 14, 2021

国药准字H11020569

Drug Information

羟基脲片

片剂

0.25g

化学药品

September 14, 2021

Company Information

Applicant Company

河北省保定市安国市义丰大路1号

Manufacturing Company

河北省保定市安国市义丰大路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

羟基脲片 - NMPA 批准文号 | MedPath